Live Breaking News & Updates on Head Of Corporate Communications Investor Relations

Stay updated with breaking news from Head of corporate communications investor relations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Basilea Pharmaceutica AG: Basilea shareholders approve all proposals of the board of directors at the annual general meeting

Basilea Pharmaceutica AG: Basilea shareholders approve all proposals of the board of directors at the annual general meeting
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Basel Stadt , Switzerland General , Dennis Riedl , Martin Nicklasson , Thomas Werner , Nicole Onetto , Leonard Kruimer , Nils Schr , Caroline Cron , Domenico Scala , Pricewaterhousecoopers Ltd , Basilea Pharmaceutica International Ltd , Head Of Corporate Communications Investor Relations , Basilea Pharmaceutica Ltd , Swiss Exchange , Pharmaceutica Ltd , Carole Sable , Corporate Communications , Pharmaceutica International Ltd , Aktien Sie ,

Basilea shareholders approve all proposals of the board of directors at the annual general meeting

24.04.2024 - Allschwil, Switzerland, April 24, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported that shareholders . ....

Switzerland General , Basel Stadt , Martin Nicklasson , Caroline Cron , Nicole Onetto , Thomas Werner , Domenico Scala , Leonard Kruimer , Nils Schr , Head Of Corporate Communications Investor Relations , Pricewaterhousecoopers Ltd , Swiss Exchange , Basilea Pharmaceutica International Ltd , Basilea Pharmaceutica Ltd , Carole Sable , Corporate Communications , Pharmaceutica International Ltd ,

EQS-Adhoc: Deutsche Beteiligungs AG: in-tech investment sold – unexpected contribution of 13 million euros to DBAG's second quarter 2023/2024 net income - adhoc - Börsennachrichten

EQS-Adhoc: Deutsche Beteiligungs AG: in-tech investment sold – unexpected contribution of 13 million euros to DBAG's second quarter 2023/2024 net income - adhoc - Börsennachrichten
stock-world.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stock-world.de Daily Mail and Mail on Sunday newspapers.

Roland Rapelius , Head Of Corporate Communications Investor Relations , Deutsche Beteiligungs , German Securities , Annual Report , Corporate Communications ,

Deutsche Beteiligungs AG: in-tech investment sold – unexpected contribution of 13 million euros to DBAG's second quarter 2023/2024 net income

Deutsche Beteiligungs AG: in-tech investment sold – unexpected contribution of 13 million euros to DBAG's second quarter 2023/2024 net income
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Roland Rapelius , Head Of Corporate Communications Investor Relations , Deutsche Beteiligungs , German Securities , Annual Report , Corporate Communications ,

Basilea awarded CARB-X grant to develop recently acquired novel class of antibiotics

Allschwil, Switzerland, April 09, 2024 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal. ....

Switzerland General , Basel Stadt , Nils Schr , Laurenz Kellenberger , Head Of Corporate Communications Investor Relations , Biomedical Advanced Research , Administration For Strategic Preparedness , Human Services , Basilea Pharmaceutica Ltd , Basilea Pharmaceutica International Ltd , Development Authority , Germany Federal Ministry Of Education , Swiss Exchange , Boston University , Us Department Of Health , World Health Organization , Pharmaceutica Ltd , Chief Scientific Officer , Strategic Preparedness , Federal Ministry , Resistant Threats , Priority Bacterial Pathogens , Corporate Communications , Pharmaceutica International Ltd , Science Advances ,